Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.390
-0.400 (-10.55%)
At close: Apr 7, 2026, 4:00 PM EDT
3.590
+0.200 (5.90%)
After-hours: Apr 7, 2026, 7:36 PM EDT
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
$581,921
Profits / Employee
$27,588
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,012 | 13 | 1.30% |
| Dec 31, 2023 | 999 | 82 | 8.94% |
| Dec 31, 2022 | 917 | 133 | 16.96% |
| Dec 31, 2021 | 784 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Evotec SE | 4,788 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Collegium Pharmaceutical | 423 |
ALVO News
- 8 days ago - Alvotech files Annual Report with the SEC - GlobeNewsWire
- 8 days ago - Alvotech Publishes 2025 Annual Report - GlobeNewsWire
- 20 days ago - Alvotech Q4 2025 and Full Year 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Alvotech Announces Increase in Number of Own Shares - GlobeNewsWire
- 2 months ago - Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® - GlobeNewsWire
- 2 months ago - Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates - GlobeNewsWire
- 3 months ago - Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire